A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1998
10/21/1998	CN1040328C Preparation method of complex salts of hematoporphyrin and of its derivatives
10/21/1998	CN1040327C Pyrido [2,3-d) pyrimidine-2,4-(1H, 3H)-diones and -2(1H,3H)-ones, manufacture method and use thereof
10/21/1998	CN1040326C Preparation method of imidazopyridine PAF/H1 antagonists
10/21/1998	CN1040324C New thiazolidindiones and drugs containing them
10/21/1998	CN1040323C Thiazolidine derivative
10/21/1998	CN1040322C Pyrimidines compounds
10/21/1998	CN1040321C Pyran-2-ones and 5,6-dihydropyran-2-ones, medicine composition containing them and pharmacy use thereof
10/21/1998	CN1040320C Secoaporphine compound and prepn. method and composition medicine containing same
10/21/1998	CN1040319C (1)-Ritodrine
10/21/1998	CN1040288C Use of 1,3-dithiole-2-isodipropyl malonate in preparing medicine for accelerating wound healing
10/20/1998	US5824811 22-Thiavitamin D3 derivatives
10/20/1998	US5824805 Branched hydrazone linkers
10/20/1998	US5824784 Genetic engineering with polypeptides and proteins
10/20/1998	US5824775 Human netrin-1
10/20/1998	US5824774 Chimeric isoprenoid synthases and uses thereof
10/20/1998	US5824707 Administering copper citrate
10/20/1998	US5824706 Method, compositions, and apparatus for treating and preventing respiratory viral infections
10/20/1998	US5824703 Instilling a liquid mixture of high vapor pressure perfluorocarbon through the trachea of a mammal
10/20/1998	US5824702 Antioxidant behavior, prevents molecular changes leading to skin cancer, prevents protooncogene expression and tumorigenesis
10/20/1998	US5824700 Ortho-quinone derivatives novel synthesis therefor and their use in the inhibition of neoplastic cell growth
10/20/1998	US5824698 Staphylococcus, enterococcus or heliobacter
10/20/1998	US5824696 Medicaments
10/20/1998	US5824694 Thiazolidine derivatives for the treatment of psoriasis
10/20/1998	US5824693 Method for treatment for pulmonary disease
10/20/1998	US5824692 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
10/20/1998	US5824691 Guanidine derivatives as inhibitors of Na+ /H+ exchange in cells
10/20/1998	US5824688 HIV protease inhibitors
10/20/1998	US5824687 Pyridinium salts and their use for the control of helicobacter bacteria
10/20/1998	US5824686 Method of treating androgenic alopecia with 5-alpha reductase inhibitors
10/20/1998	US5824685 Vision defects and gene expression
10/20/1998	US5824684 Acetylcholine esterase reactivator to treat drug addiction
10/20/1998	US5824682 Vasoconstrictive dihydrobenzopyran derivatives
10/20/1998	US5824681 Immunomodulating effect
10/20/1998	US5824680 Ipsapirone for the treatment of alzheimer's disease by improving memory
10/20/1998	US5824679 Thrombin inhibitors; anticoagulants; cardiovascular disorders, arteriosclerosis; antitumor agents
10/20/1998	US5824678 Morpholine derivatives and their use as therapeutic agents
10/20/1998	US5824677 Substituted with heterocyclic ring, antiinflammatory, immunosuppressive
10/20/1998	US5824675 Preventive and therapeutic agent for kidney diseases
10/20/1998	US5824674 Brefeldin A derivatives and their utility in the treatment of cancer
10/20/1998	US5824673 Pharmaceutical compositions comprising metal complexes
10/20/1998	US5824672 Preservation of tissue during removal, storage and implantation
10/20/1998	US5824671 Vaginal atrophy, hypogonadism and loss of collagen or connective tissues
10/20/1998	US5824670 17-deoxycorticosteroid-21- O!carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds
10/20/1998	US5824669 Treating asthma
10/20/1998	US5824668 Steroid and cyclodextrin used to treat obesity, diabetes, hpercorticoidism, anemia
10/20/1998	US5824667 Estradiol or ethynylestradiol and drospirenone or cyproterone acetate; low dosage; side effect reduction
10/20/1998	US5824665 Reduction of hair growth
10/20/1998	US5824664 Suppression of HIV expression by organic thiophosphate
10/20/1998	US5824663 Alternative enzyme substrates as deodorants
10/20/1998	US5824662 Treatment of global and focal ischemia using naaladase inhibitors
10/20/1998	US5824661 Sulfur-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism
10/20/1998	US5824658 Topical composition containing hyaluronic acid and NSAIDS
10/20/1998	US5824655 Anti-transforming growth factor-β gene therapy
10/20/1998	US5824653 Anthelmintic compositions for equidae
10/20/1998	US5824650 Antiinflammatory agents for skin by applying topically substance p antagonist
10/20/1998	US5824550 Voltage-gated calcium channel and antisense oligonucleotides thereto
10/20/1998	US5824519 A dna sequence comprising a specific binding promoter encoding a ribozyme as antitumor agents, viricides, antiproliferative agents; drug delivery
10/20/1998	US5824500 Nucleic acid encoding novel human KDEL receptor
10/20/1998	US5824490 Method for detecting prostate cancer using a reagent which binds prostate cancer-1 protein
10/20/1998	US5824484 RXR homodimer formation
10/20/1998	US5824336 Chewable flubendazole tablets for companion animals
10/20/1998	US5824334 Substitute for cigarettes to deliver nicotine
10/20/1998	US5824322 Compositions and methods for growth promotion
10/20/1998	US5824320 Cosmetic or pharmaceutical compositions containing, as active ingredient, mangiferine or its derivatives, in pure form or in plant extracts
10/20/1998	US5824313 Administering specific antigen and lymphoid organ modifying agent selected from calcipotriene and 1,25-dihydroxy-16-ene vitamin d3; immune resonse against hepatitis, flu, diphtheria, tetanus, pertussis, measles, mumps, rubella, polio, pneumonia,
10/20/1998	US5824304 Peripheralization of hematopoietic stem cells
10/20/1998	US5824080 Photochemistry for the preparation of biologic grafts--allografts and xenografts
10/20/1998	CA2161737C Metronidazole gel
10/20/1998	CA2066924C Use of lysine pyrrolidonecarboxylate and(or) arginine pyrrolidonecarboxylate as an antioxidant in pharmaceutical or cosmetic composition
10/20/1998	CA2049729C Methods and compositions containing vitamin d compounds for improvement of skin conditions
10/17/1998	CA2243983A1 Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect
10/17/1998	CA2234778A1 A process for the preparation of moenomycin a
10/16/1998	CA2234789A1 New naphthylpiperazine derivatives
10/15/1998	WO1998045712A2 20 human secreted proteins
10/15/1998	WO1998045443A1 Radioisotope concentrator methods and compositions
10/15/1998	WO1998045432A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
10/15/1998	WO1998045427A2 Insulin-like growth factor agonist peptides
10/15/1998	WO1998045420A1 Pca3, pca3 genes, and methods of use
10/15/1998	WO1998045335A1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
10/15/1998	WO1998045330A1 Antiviral protease inhibitors
10/15/1998	WO1998045322A2 Diagnosis method and reagents
10/15/1998	WO1998045316A1 Novel 4- halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same
10/15/1998	WO1998045315A1 Estra-5(10),7-dienes with estrogenic activity
10/15/1998	WO1998045314A1 Composition and method for treatment of cmv infections
10/15/1998	WO1998045309A1 Novel phosphate compounds and their use as medicaments
10/15/1998	WO1998045301A1 Vinca alkaloid antimitotic halogenated derivatives
10/15/1998	WO1998045299A1 Crystalline amine salt of cefdinir
10/15/1998	WO1998045297A1 1,2,3,4-TETRAHYDRO-BENZOFURO[3,2-c]PYRIDINE DERIVATIVES__
10/15/1998	WO1998045294A1 Compounds
10/15/1998	WO1998045293A1 Pyrimido-isoquinoline compounds with anticonvulsive action
10/15/1998	WO1998045292A1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties
10/15/1998	WO1998045291A1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties
10/15/1998	WO1998045288A1 Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogen receptor modulators
10/15/1998	WO1998045287A1 Treatment of central nervous system disorders with selective estrogen receptor modulators
10/15/1998	WO1998045286A1 Prevention of breast cancer with selective estrogen receptor modulators
10/15/1998	WO1998045285A1 Somatostatin agonists
10/15/1998	WO1998045276A2 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinones useful as hiv reverse transcriptase inhibitors
10/15/1998	WO1998045275A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity
10/15/1998	WO1998045270A1 Pharmacological agents
10/15/1998	WO1998045268A1 Nicotinamide derivatives

1 ... 6593 6594 6595 6596 6597 6598 6599 6600 6601 6602 6603 6604 6605 6606 6607 6608 6609 6610 6611 6612 6613 ... 7860